P
ANIP icon

Pitcairn’s ANI Pharmaceuticals ANIP Stock Holding History

Pitcairn’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,764
Closed -$293K – 445
2019
Q4 		$293K Buy
4,764
+753
+19% +$49.9K 0.03% 406
2019
Q3 		$292K Sell
4,011
-243
-6% -$18.2K 0.03% 392
2019
Q2 		$350K Buy
4,254
+27
+0.6% +$1.92K 0.04% 336
2019
Q1 		$299K Buy
+4,227
New +$249K 0.03% 358
2018
Q4 		– Sell
-3,800
Closed -$214K – 455
2018
Q3 		$214K Sell
3,800
-297
-7% -$18.2K 0.02% 503
2018
Q2 		$274K Buy
4,097
+76
+2% +$4.75K 0.03% 436
2018
Q1 		$234K Buy
+4,021
New +$255K 0.02% 464

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return